BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 7176806)

  • 21. Differing effect of chenodeoxycholic acid and ursodeoxycholic acid on bile acids in rat colonic wall and contents.
    Kurtz WJ; Guldutuna S; Leuschner U
    Tokai J Exp Clin Med; 1988 Jun; 13(2):91-7. PubMed ID: 3250006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocellular bile acid transport and ursodeoxycholic acid hypercholeresis.
    Scharschmidt BF; Lake JR
    Dig Dis Sci; 1989 Dec; 34(12 Suppl):5S-15S. PubMed ID: 2689116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effect of ursodeoxycholate and its taurine conjugate on biliary transport maximum of bilirubin in the rat.
    Sánchez Pozzi EJ; Mottino AD; Sisti A; Roma MG
    Life Sci; 1995; 57(10):973-81. PubMed ID: 7643722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholesterol absorption during bile acid feeding. Effect of ursodeoxycholic acid (UDCA) administration.
    Ponz de Leon M; Carulli N; Loria P; Iori R; Zironi F
    Gastroenterology; 1980 Feb; 78(2):214-9. PubMed ID: 7350042
    [No Abstract]   [Full Text] [Related]  

  • 25. Permeability of the rat biliary tree to ursodeoxycholic acid.
    Farges O; Corbic M; Dumont M; Maurice M; Erlinger S
    Am J Physiol; 1989 Apr; 256(4 Pt 1):G653-60. PubMed ID: 2705526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Difference in the effects of ursodeoxycholate and its taurine conjugate on the biliary excretion of sulfobromophthalein in the rat.
    Kanai S; Kitani K; Sato Y
    J Hepatol; 1990 Mar; 10(2):174-9. PubMed ID: 2332588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of Na+/H+ exchange in the rat is associated with decreased ursodeoxycholate hypercholeresis, decreased secretion of unconjugated urodeoxycholate, and increased ursodeoxycholate glucuronidation.
    Lake JR; Renner EL; Scharschmidt BF; Cragoe EJ; Hagey LR; Lambert KJ; Gurantz D; Hofmann AF
    Gastroenterology; 1988 Aug; 95(2):454-63. PubMed ID: 2455672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biliary lipid metabolism in gallstone disease and during gallstone dissolution treatment.
    Nilsell K
    Acta Chir Scand Suppl; 1985; 528():1-38. PubMed ID: 3866449
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of Na+ replacement and amiloride on ursodeoxycholic acid-stimulated choleresis and biliary bicarbonate secretion.
    Lake JR; Van Dyke RW; Scharschmidt BF
    Am J Physiol; 1987 Feb; 252(2 Pt 1):G163-9. PubMed ID: 3826345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of ursodeoxycholate on the biliary excretion of cefotiam and sulbenicillin in patients with percutaneous transhepatic biliary drainage.
    Higashi K; Hayakawa T; Katagiri K; Tsukada K; Ito K; Hoshino M; Miyaji M; Takeuchi T; Yamamoto T
    Antimicrob Agents Chemother; 1988 May; 32(5):726-9. PubMed ID: 3164988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A difference in stimulatory effects on pancreatic exocrine secretion between ursodeoxycholate and trypsin inhibitor in the rat.
    Miyasaka K; Kitani K
    Dig Dis Sci; 1986 Sep; 31(9):978-86. PubMed ID: 2426065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intestinal absorption of ursodeoxycholic, glycoursodeoxycholic and tauroursodeoxycholic acids in rats.
    Ota M; Minami Y; Hoshita T
    J Pharmacobiodyn; 1985 Feb; 8(2):114-8. PubMed ID: 4009402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative study of the effects of an average dose of chenodesoxycholic acid and a high dose of ursodesoxycholic acid (dosage equivalents: 15 mg/kg/day) on the composition of lipids and bile acids in the bile of patients with radiotransparent biliary lithiasis].
    Garrido G; Bretó M; Pérez F; Berenguer J
    Rev Clin Esp; 1983 Jul 15-31; 170(1-2):31-6. PubMed ID: 6635274
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of acid-base balance and acetazolamide on ursodeoxycholate-induced biliary bicarbonate secretion.
    Garcia-Marin JJ; Dumont M; Corbic M; de Couet G; Erlinger S
    Am J Physiol; 1985 Jan; 248(1 Pt 1):G20-7. PubMed ID: 3966558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increase of bile acid production by tacrolimus in the rat liver.
    Mizuta K; Kobayashi E; Uchida H; Hishikawa S; Kawarasaki H
    Transplant Proc; 2003 Feb; 35(1):437-8. PubMed ID: 12591477
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis.
    Nilsell K; Angelin B; Leijd B; Einarsson K
    Gastroenterology; 1983 Dec; 85(6):1248-56. PubMed ID: 6628924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of tauroursodeoxycholic acid and taurine supplementation on biliary bile acid composition.
    Batta AK; Salen G; Shefer S; Tint GS; Dayal B
    Hepatology; 1982; 2(6):811-6. PubMed ID: 7141393
    [No Abstract]   [Full Text] [Related]  

  • 38. The choleretic effects of N-acetylglucosaminides, major urinary metabolites of ursodeoxycholic acid, in bile fistula rats.
    Iwaki T; Hirabayashi N; Miyazawa N; Takeuchi Y; Ishizaki K; Sakakura H; Kasai H; Maeda M; Araki T
    Eur J Pharmacol; 1998 Dec; 363(1):41-8. PubMed ID: 9877080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic biotransformation and choleretic effect of 7-ketolithocholic acid in the rat.
    Kanai S; Sato Y; Nokubo M; Kitani K
    Lipids; 1989 Oct; 24(10):859-65. PubMed ID: 2811609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of 1H NMR spectroscopy (T2 relaxation times) to examine the effects of conjugated ursodeoxycholic acid on phospholipid fluidity of human gallbladder bile.
    Gilani SS; Ellul JP; Murphy GM
    Biochem Soc Trans; 1997 Feb; 25(1):23S. PubMed ID: 9056921
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.